New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
Sanofi's venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease In the LEAP2MONO phase 3 study, venglustat, dosed orally once daily, demonstrated clinically meaningful effic ...
Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...
Learn how to understand dog blood work with this comprehensive guide. Decode CBC, chemistry panels, liver, and kidney values.